Virology and Vaccine immunology: Establishing powerful vaccine platforms against pathogens with pandemic potential
We utilise modern protein-based vaccine formulae and platforms such as virus-like particles, virus-like particle-based vaccine platforms and recombinant proteins against current and new, emerging pathogens. These technologies are widely applicable and modifiable.
Efficacy and safety
We conduct comprehensive pre-clinical animal studies and immunological analyses for the developed vaccines. We set-up mouse infection models to study the virus pathogenesis and use the developed animal models to assess candidate vaccine efficacy and safety.
We perform versatile quality control analyses for the vaccines and develop industrially compatible production methods to ensure rapid release of the developed vaccines into clinical evaluation.